Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View

Dr. Rishi Wadhera

General Cardiology · BIDMC

View

Dr. Robert Harrington

General Cardiology · WCM

View

Dr. Mike Gaziano

General Cardiology · BWH

View

Dr. Tyler Gluckman

General Cardiology · Providence

View

Dr. Cayla Pichan

General Cardiology · UT Southwestern

View

Dr. Sanjiv Kaul

General Cardiology · OHSU

View

Dr. Emily Lau

General Cardiology · MGH

View

Dr. Sarah Ashley

General Cardiology · Emory University Hospital

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    CRDr. Christian Ruff

    Dr. Christian Ruff

    Cardiology · General Non-Invasive Cardiology
    Mass General Brigham
    christianruff

    Research

    Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarin

    2026

    Via Journal of Thrombosis and Haemostasis

    Research

    Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis from COMBINE-AF

    2026

    Via European Journal of Internal Medicine

    Jan 30, 2026Journal Article

    Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin.

    ​

    Written by 1 Roon author & 12 others

    Via The American Heart Association Journals

    Research

    Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 Trial

    2026

    Via JAMA Cardiology

    Research

    Antiphospholipid antibodies and cardiovascular thrombosis

    2026

    Via Nature Reviews Cardiology

    Research

    Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study

    2026

    Via Journal of the American College of Cardiology

    Research

    Direct oral anticoagulants vs warfarin in Asian vs non-Asian patients with atrial fibrillation: a patient-level meta-analysis from COMBINE AF

    2026

    Via European Heart Journal

    Research

    Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid lowering

    2025

    Via Nature Medicine

    Research

    Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases

    2025

    Via Nature Genetics

    Research

    Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk

    2025

    Via Nature Genetics

    Research

    Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation

    2025

    Via Journal of the American College of Cardiology

    Research

    Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes

    2025

    Via Nature Genetics

    May 19, 2025Journal Article

    Factor XI Inhibition for Atrial Fibrillation: Where Do We Stand?

    ​

    Written by 1 Roon author & 2 others

    Via The American Heart Association Journals

    Research

    Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71

    2025

    Via Journal of the American College of Cardiology

    Jun 23, 2025Journal Article

    Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial.

    ​

    Written by 1 Roon author & 16 others

    Via The American Heart Association Journals